HCAT's Vitalware sale brings relief, and a reckoning

Health Catalyst's divestiture of Vitalware offered balance sheet relief, but also raised questions about the sagacity of its long-running acquisition strategy.

Why it matters: HCAT will have to prove its remaining businesses can grow organically, or else accept mounting investor calls for a broader review.